Occupational exposure of pharmacy technicians and cleaning staff to cytotoxic drugs in Dutch hospitals

References

• Breukels O, van der Gronde T, Simons-Sanders K, Crul M. 2018. Antineoplastic drug contamination on the outside of prepared infusion bags. Int J Pharm Compd. 22(4):345–349.
   PubMedGoogle Scholar
• Chauchat L, Tanguay C, Caron NJ, Gagné S, Labrèche F, Bussières JF. 2019. Surface contamination with ten antineoplastic drugs in 83 Canadian centers. J Oncol Pharm Pract. 25(5):1089–1098. doi:10.1177/1078155218773862
   PubMed Web of Science ®Google Scholar
• Connor TH, DeBord DG, Pretty JR, Oliver MS, Roth TS, Lees PSJ, Krieg EF, Rogers B, Escalante CP, Toennis CA, et al. 2010. Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. J Occup Environ Med. 52(10):1019–1027. doi:10.1097/JOM.0b013e3181f72b63
   PubMed Web of Science ®Google Scholar
• Crauste-Manciet S, Sessink PJM, Ferrari S, Jomier J-Y, Brossard D. 2005. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Ann Occup Hyg. 49(7):619–628. doi:10.1093/annhyg/mei045
   PubMed Web of Science ®Google Scholar
• Crul M, Simons-Sanders K. 2018. Carry-over of antineoplastic drug contamination in Dutch hospital pharmacies. J Oncol Pharm Pract. 24(7):483–489. doi:10.1177/1078155217704990
   PubMed Web of Science ®Google Scholar
• Cullen AC, Frey HC. 1999. Probabilistic techniques in exposure assessment: a handbook for dealing with variability and uncertainty in models and inputs. New York: Plenum Press.
   Google Scholar
• EC directive 2004/37/EC. 2004. Directive 2004/37/EC of the European parliament and of the council on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (Sixth individual Directive within the meaning of Article 16(1) of Council Directive 89/391/EEC). April 29. http://eur-ex.europa.eu/LexUriServ/LexUriServ.do?uri¼OJ:L:2004:229:0023:0034:EN:PDF.
   Google Scholar
• Favier B, Gilles L, Ardiet C, Latour JF. 2003. External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers. J Oncol Pharm Pract. 9(1):15–20. doi:10.1191/1078155203jp102oa
   Google Scholar
• Fleury-Souverain S, Mattiuzzo M, Mehl F, Nussbaumer S, Bouchoud L, Falaschi L, Gex-Fabry M, Rudaz S, Sadeghipour F, Bonnabry P, et al. 2015. Evaluation of chemical contamination of surfaces during the preparation of chemotherapies in 24 hospital pharmacies. Eur J Hosp Pharm. 22(6):333–341. doi:10.1136/ejhpharm-2014-000549
   Google Scholar
• Fransman W, Vermeulen R, Kromhout H. 2005. Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health. 78(5):403–412. doi:10.1007/s00420-004-0595-1
   PubMed Web of Science ®Google Scholar
• Fransman W, Roeleveld N, Peelen S, de Kort W, Kromhout H, Heederik D. 2007. Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes. Epidemiology. 18(1):112–119. doi:10.1097/01.ede.0000246827.44093.c1
   PubMed Web of Science ®Google Scholar
• Gurusamy LS, Best KM, Tanguay C, Lennan E, Korva M, Bussieres J-F. 2018. Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff. Cochrane Database Syst Rev. 3(3):CD012860. doi:10.1002/14651858.CD012860.pub2.
   PubMedGoogle Scholar
• Hedmer M, Tinnerberg H, Axmon A, Jönsson BAG. 2008. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Int Arch Occup Environ Health. 81(7):899–911. doi:10.1007/s00420-007-0284-y
   PubMed Web of Science ®Google Scholar
• Helsel RD. 2012. Statistics for censored environmental data using minitab and R. Hoboken, NJ: John Wiley & Sons.
   Google Scholar
• Hon CY, Teschke K, Demers PA, et al. 2014. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system. Ann Occup Hyg. 58:761–770. doi:10.1093/annhyg/meu019
   PubMed Web of Science ®Google Scholar
• Kibby T. 2017. A review of surface wipe sampling compared to biologic monitoring for occupational exposure to antineoplastic drugs. J Occup Environ Hyg. 14(3):159–174. doi:10.1080/15459624.2016.1237026
   PubMed Web of Science ®Google Scholar
• Meyster T, Fransman W, van Hemmen J, et al. 2006. A probabilistic assessment of the impact of interventions on oncology nurses’ exposure to antineoplastic agents. Occup Environ Med. 63:530–537.
   PubMed Web of Science ®Google Scholar
• Ng MG, de Poot S, Schmid K, Cowie H, Semple S, van Tongeren M. 2014. A preliminary comparison of three dermal exposure sampling methods: rinses, wipes and cotton gloves. Environ Sci Process Impacts. 16(1):141–147. doi:10.1039/c3em00511a
   PubMed Web of Science ®Google Scholar
• NIOSH. 2004. Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. Publication Number 2004-165.
   Google Scholar
• Schierl RA, Bohlandt A, Nowak D. 2009. Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Ann Occup Hyg. 53(7):703–711. doi:10.1093/annhyg/mep050
   PubMed Web of Science ®Google Scholar
• Selevan SG, Lindbohm ML, Hornung RW, Hemminki K. 1985. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med. 313(19):1173–1178. doi:10.1056/NEJM198511073131901
   PubMed Web of Science ®Google Scholar
• Stichting Arbeidsmarkt Ziekenhuizen (STAZ). 2012. Branche-afspraak cytotoxica ziekenhuizen. https://www.betermetarbo.nl/fileadmin/user_upload/Gevaarlijke_stoffen/Branche-afspraak-Cytotoxica.pdf.
   Google Scholar
• Stücker I, Caillard JF, Collin R, Gout M, Poyen D, Hémon D. 1990. Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health. 16(2):102–107. doi:10.5271/sjweh.1811
   PubMed Web of Science ®Google Scholar
• Turci R, Sottani C, Spagnoli G, Minoia C. 2003. Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. J Chrom B. 789(2):169–209. doi:10.1016/S1570-0232(03)00100-4
   PubMed Web of Science ®Google Scholar
• Tuerk J, Kiffmeyer TK, Hadtstein C, Heinemann A, Hahn M, Stuetzer H, Kuss H-M, Eickmann U. 2011. Development and validation of an LC-MS/MS procedure for environmental monitoring of eight cytotoxic drugs in pharmacies. Int J Environ Anal Chem. 91(12):1178–1190. doi:10.1080/03067319.2010.494769
   Web of Science ®Google Scholar
• Valanis B, Vollmer WM, Steele P. 1999. Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists. J Occup Environ Med. 41(8):632–638. doi:10.1097/00043764-199908000-00004
   PubMed Web of Science ®Google Scholar
• Wallemacq PE, Capron A, Vanbinst R, Boeckmans E, Gillard J, Favier B. 2006. Permeability of 13 different gloves to 13 cytotoxic agents under controlled dynamic conditions. Am J Health Syst Pharm. 63(6):547–556. doi:10.2146/ajhp050197
   PubMed Web of Science ®Google Scholar